Wed, Sep 17, 2014, 8:23 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • mdwhittier mdwhittier Sep 20, 2013 10:40 AM Flag

    News Digested - Trading Has Flatlined - FDA on Horns of Dilemma

    90 minutes is all it took for stop losses to be taken out, fear and greed to cause huge swings, shorts to cover and now more normal trading. Not much offered on the sell side in terms of block trades; just retail action from here on out. SRPT comes out the winner in this race. Will SRPT need to conduct a Ph 3 with the absence of safety / toxicity issues? Will the FDA make the parents of DMD boys wait another year for a life saving drug to be available? The FDA is on the horns of a dilemma.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
22.94+0.64(+2.87%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.